“사하건마🎐 ▶OPDAL050.컴◀오피달리기 🏘사하립카페☀️사하OP😐사하풀싸롱🌊🍏사하풀싸롱🚴사하키스방💷사하키스방🐙”的搜索结果，显示 61-70 项，共有 4910 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

2. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop and maintain a registry of clinical data and biological specimens from patients with immune system related blood ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

4. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

5. -

   It also may be done to repair a skull defect caused by an injury, an infection, a condition present at birth or removal of a tumor involving the skull.

6. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 血液科- 临床试验- 妙佑医疗国际

    The objectives of this study are to analyze impact of radiation on fertility, to correlate the clinical outcome of fertility after chemotherapy and or ...